COMPARATIVE CHARACTERISTIC'S OF IMMUNE STATUS OF PAT I ENTS WITH CHRONIC FORMS OF VIRAL HEPATITIS В, C, D AND HEALTHY INDIVIDUALS

Cover Page


Cite item

Full Text

Abstract

Aim. Evaluate immune status in patients with chronic hepatitis (CH) depending on type of causative agent and severity of the infectious process. Materials and methods. 232 residents of Yakutia including 127 patients with various forms of chronic hepatitis and 105 healthy individuals were examined. Relative levels of mature T-lymphocytes (CD3+), T-helpers (CD4+), T-suppressors (CD8+), B-lymphocytes (CD72+) and natural killers (CD16+) were studied by flow cytometry, as well as concentration of sera immune globulins of classes A, M and G by ELISA. Results. In patients with chronic hepatitis of various forms, a decrease of expression of differentiating antigens - CD3+, CD4+, CD72+ on the surface of lymphocytes and concentration of sera immune globulins was established. In CHD patients in phase of monoreplication high activity of the infectious process is accompanied by a shift of immune regulatory index to the increase of activity of cytotoxic cells with simultaneous development of deficiency of mature functionally active T-lymphocytes. In the group of patients with hepatitis D virus with liver cirrhosis normal concentration of sera immune globulins is retained against the decrease of the number of T-helpers and B-lymphocytes. Conclusion. In patients with various forms of viral hepatitis acquired immune deficiency can emerge, which is often accompanied by enhancement of NK-cell activity. The noted reduction of the number of mature functionally active T-cells, as well as main classes of sera antibodies could be connected with immune system load during a chronic infectious process.

About the authors

S. I. Semenov

Research Institute of Health of Ammosov North-Eastern Federal University

Author for correspondence.
Email: noemail@neicon.ru
Россия

A. I. Fedorov

Research Institute of Health of Ammosov North-Eastern Federal University

Email: noemail@neicon.ru
Россия

S. S. Maksimova

Research Institute of Health of Ammosov North-Eastern Federal University

Email: noemail@neicon.ru
Россия

K. M. Stepanov

Research Institute of Health of Ammosov North-Eastern Federal University

Email: noemail@neicon.ru
Россия

F. A. Platonov

Research Institute of Health of Ammosov North-Eastern Federal University

Email: noemail@neicon.ru
Россия

References

  1. Балмасова И.П., Сепиашвили Р.И., Малова Е.С. Молекулярная биология вируса гепатита В и иммунопатогенез хронического вирусного гепатита В. Журн. микробиол. 2016, 2: 119-126.
  2. Кетлинский С.А., Калинина Н.М. Цитотоксины мононуклеарных фагоцитозов в регуляции реакции воспаления и иммунитета. Иммунология. 1995, 3: 30-42.
  3. Кинго З.Н., Яковлев А.А., Виноградова Е.Н. и др. Иммунологическая характеристика больных вирусными гепатитами. Вирусные гепатиты и другие актуальные инфекции. СПб, 1997.
  4. Нечаев В.В., Иванов А.К., Пантелеев А.М. Социально-значимые инфекции. СПб, Береста, 2011.
  5. Учайкин В.Ф., Нисевич Н.И., Чередниченко Т.В. Вирусные гепатиты у детей. М., 1994...
  6. Хронический вирусный гепатит. Под ред. В.В. Серова, З.Г. Апросимовой. М., Медицина, 2004.
  7. Яригин А.А., Пинчук В.Г., Гриневич Ю.А. Структура тимуса и дифференцировка Т-лимфоцитов. Киев, 1991.
  8. Ganem D., Schneider R.J. Hepadnaviridae: The viruses and their replication. In: Knipe D.M. et al. (ed.). Fields Virology, Philadelphia, Lippincott Williams and Wilkins. 2001, p. 2923-2969.
  9. Naoumov N.V. Hepatitis C virus-specific CD4+ T cells:do they help or damage? Am. J. Gastroenterol. 1999, 117: 1012-1014.
  10. Pawlotski J.M. Pathophysiology of hepatitis C virus infection and related liver disease. Trends Microbiol. 2004, 12: 96-102.
  11. Schaefer S. Hepatitis В virus: significance ofgenotypes. J. Viral. Hepat. 2005,12 (2): 111124.
  12. Shoukry N.H., Cawthon A.G., Walker C.M. Cell-mediated immunity and the outcome of hepatitis C virus. Ann. Rev. Microbiol. 2004, 58: 391-424.
  13. Thio C.L., Seaberg E.C., Skolasky R.J. et. al. Multicenter AIDS cohort study. HIV-1, hepatitis В virus, and risk of leaver-related mortality in the multicenter cohort study. Lancet. 2002, 360: 1921-1926.
  14. Yoshioca K., Kakumu S., Hayashi H. et al. Anti-hepatitis C antibodies in patients with, chronics non-A, non-B hepatitis: relation to disease progression and effect of interferon alpha. Am. J. Gastroenterol. 1991, 86:1495-1499.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Semenov S.I., Fedorov A.I., Maksimova S.S., Stepanov K.M., Platonov F.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies